Cisternography and ventriculography gadopentate dimeglumine-enhanced MR imaging in pediatric patients: Preliminary report

American Journal of Neuroradiology

Volumn 28, Issue 5, 2007, Pages 889-894

  Munoz A ^a   Hinojosa, J ^a   Esparza, J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOPENTATE DIMEGLUMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANASTOMOSIS; ARACHNOIDITIS; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; BRAIN VENTRICLE TUMOR; BRAIN VENTRICULOGRAPHY; CHILD; CISTERNOGRAPHY; CLINICAL ARTICLE; CONGENITAL HYDROCEPHALUS; DECISION MAKING; DIAGNOSTIC PROCEDURE; ENCEPHALOMENINGOCELE; FEMALE; HUMAN; HYDROCEPHALUS; INFANT; INFORMED CONSENT; LIQUORRHEA; LUMBAR PUNCTURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; RADIODIAGNOSIS; SPINAL CORD TUMOR;

ADOLESCENT; ARACHNOIDITIS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM DISEASES; CEREBRAL VENTRICULOGRAPHY; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; HYDROCEPHALUS; INFANT; INFANT, NEWBORN; INJECTIONS, SPINAL; MAGNETIC RESONANCE IMAGING; MALE; MENINGOMYELOCELE; MYELOGRAPHY; PILOT PROJECTS; SKULL FRACTURES; SUBARACHNOID SPACE;

EID: 34248673473     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Aydin K, Guven, Sencer S, et al. MRI cisternography with gadolinium-containing contrast medium: its role, advantages and limitations in the investigation of rhinorrhoea. Neuroradiology 2004;46:75-80. Epub 2003 Nov 13
2. Wenzel R, Leppien A. Gadolinium-myelocisternography for cerebrospinal fluid rhinorrhoea. Neuroradiology 2000;42:874-80
3. Siebner HR, Gräfin von Einsiedel H, Conrad B, et al. Magnetic resonance ventriculography with gadolinium DTPA: report of two cases. Neuroradiology 1997;39:418-22
4. Zeng QY, Xiong L, Jinkins JR, et al. Intrathecal gadolinium-enhanced MR myelography and cisternography: a pilot study in human patients. AJR Am J Roentgenol 1999;173:1109-15
5. Turgut TE, Ercan N, Kaymaz M, et al. Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR cisternography used to determine potential communication between the cerebrospinal fluid pathways and intracranial arachnoid cysts. Neuroradiology 2004;46:744-54
6. Di Chiro G, Knop RH, Girton ME, et al. MR cisternography and myelography with gadolinium DTPA in monkeys. Radiology 1985;157:373-77
7. Di Chiro G, Girton ME, Frank JA, et al. Cerebrospinal fluid rhinorrhea: depiction with MR cisternography in dogs. Radiology 1986;160:221-22
8. Skalpe IO, Tang GJ. Magnetic resonance imaging contrast media in the subarachnoid space: a comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs. Invest Radiol 1997;32:140-48
9. Ibarra R, Jinkins JR, Korvick D, et al. Evaluation of intrathecal gadolinium-enhanced MR cisternography in a rabbit model of traumatic nasoethmoidal CSF fistula. J Magn Reson Imaging 2000;11:20-24
10. Morris TW, Ekholm SE, Prentice LJ. The effects of gadolinium-DTPA and -DOTA on neural tissue metabolism. Invest Radiol 1991;26:1087-90
11. Ray DE, Holton JL, Nolan CC, et al. Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats. AJNR Am J Neuroradiol 1998;19:1455-62
12. Toney GM, Chavez HA, Ibarra R, et al. Acute and subacute physiologic and histologic studies of the central nervous system after intrathecal gadolinium injection in the anesthetized rat. Invest Radiol 2001;36:33-40
13. Jinkins JR, Rudwan M, Krumina G, et al. Intrathecal gadolinium-enhanced MR cisternography in the evaluation of clinically suspected cerebrospinal fluid rhinorrhea in humans: early experience. Radiology 2002;222:555-59
14. Zeng QY, Xiong L, Jinkins JR, et al. Intrathecal gadolinium-enhanced MR myelography: a pilot study in human patients (abstr). Presented at: Radiological Society of North America Scientific Program 1997; November 30-December 5, 1997; Chicago; 1997;205(P):468
15. Turgut TE, Ercan N, Krumina G, et al. Intrathecal gadolinium (gadopentetate dimeglumine) enhanced magnetic resonance myelography and cisternography: results of a multicenter study. Invest Radiol 2002;37:152-59
16. Brash RC. Methods of contrast enhancement for NMR imaging and potential applications. Radiology 1983;147:781-88
17. Rosen GM, Griffeth LK, Brown MA, et al. Intrathecal administration of nitroxides as potential contrast agents for MR imaging. Radiology 1987;163:239-43
18. Weinmann HJ, Brasch RC, Press WR, et al. Characteristics of gadolinium DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984;142:619-24
19. Hinshaw DB, Wong VC. Paramagnetic contrast agents in the evaluation of brain neoplasms. Top Magn Reson Imaging 1989;1:79-93
20. Saini S. Advances in contrast-enhanced MR imaging: principles. AJR Am J Roentgenol 1991;156:236-39
21. Hegarty SE, Millar JS. MRI in the localization of CSF fistulae: is it of any value? Clin Radiol 1997;52:768-70